Latent, high-activity olefin metathesis catalysts containing an N-heterocyclic carbene ligand

US9238709B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9238709-B2
Application numberUS-201414497387-A
CountryUS
Kind codeB2
Filing dateSep 26, 2014
Priority dateMar 29, 2004
Publication dateJan 19, 2016
Grant dateJan 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel organometallic complexes useful as olefin metathesis catalysts. The complexes have an N-heterocyclic carbene ligand and a chelating carbene ligand associated with a Group 8 transition metal center. The molecular structure of the complexes can be altered so as to provide a substantial latency period. The complexes are particularly useful in catalyzing ring closing metathesis of acyclic olefins and ring opening metathesis polymerization of cyclic olefins.

First claim

Opening claim text (preview).

We claim: 1. A method for catalyzing an olefin metathesis reaction, comprising contacting an olefinic reactant with a complex having the structure of formula (I) wherein: α and β represent single bonds or unsaturated bonds, with the proviso that α and β cannot both be unsaturated bonds; M is a Group 8 transition metal; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; Q is an organic diradical; X 1 and X 2 are anionic ligands, and may be the same or different; L 1 is a neutral electron donor ligand, and p is zero or 1; when α is a single bond, L 2 is selected from NR 7 R 8 , PR 7 R 8 , N═CR 7 R 8 , and R 7 C═NR 8 , where R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring; when α is an unsaturated bond, L 2 is selected from NR′ and PR 7 , where R 7 is as defined previously, or L 2 and Z represent adjacent atoms in an aromatic ring; Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 , and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring; m is zero or 1; n is zero or 1; and wherein L 2 and the ligand containing Q are bonded to M in a trans orientation, and wherein the olefinic reactant and the complex having the structure of formula (I) are contacted under reaction conditions selected to enable olefin metathesis; and wherein the complex having the structure of formula (I) exhibits a latency period when contacted with the olefinic reactant. 2. The method for catalyzing an olefin metathesis reaction according to claim 1 , wherein the complex has the structure of formula (II) wherein: β represents a single bond or an unsaturated bond; M is a Group 8 transition metal; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; Q is an organic diradical; X 1 and X 2 are anionic ligands, and may be the same or different; L 1 is a neutral electron donor ligand, and p is zero or 1; R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring; Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 , and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring; and wherein NR 7 R 8 and the ligand containing Q are bonded to M in a trans orientation. 3. The method for catalyzing an olefin metathesis reaction according to claim 2 , wherein R 7 and R 8 of the complex having the structure of formula (II) are C 1 -C 12 alkyl or C 5 -C 12 aryl, and Y is a substituted or unsubstituted methylene or ethylene linkage. 4. The method for catalyzing an olefin metathesis reaction according to claim 1 , wherein the complex has the structure of formula (III) wherein: β represents a single bond or an unsaturated bond; M is a Group 8 transition metal; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; Q is an organic diradical; X 1 and X 2 are anionic ligands, and may be the same or different; L 1 is a neutral electron donor ligand, and p is zero or 1; R 7 and R 8 are independently selected from substituted and/or heteroatom-containing C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, and C 5 -C 24 aryl, or R 7 and R 8 can be taken together to form a heterocyclic ring; Y and Z are linkages independently selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 , and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl, and further wherein Y and Z may represent adjacent atoms in an aromatic ring; and wherein PR 7 R 8 and the ligand containing Q are bonded to M in a trans orientation. 5. The method for catalyzing an olefin metathesis reaction according to claim 4 , wherein R 7 and R 8 of the complex having the structure of formula (III) are C 1 -C 12 alkyl or C 5 -C 12 aryl, and Y is a substituted or unsubstituted methylene or ethylene linkage. 6. The method for catalyzing an olefin metathesis reaction according to claim 5 , wherein R 7 and R 8 of the complex having the structure of formula (III) are phenyl and Y is ethylene. 7. The method for catalyzing an olefin metathesis reaction according to claim 1 , wherein the complex has the structure of formula (IV) wherein: M is a Group 8 transition metal; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; Q is an organic diradical; X 1 and X 2 are anionic ligands, and may be the same or different; L 1 is a neutral electron donor ligand, and p is zero or 1; Y is a linkage selected from hydrocarbylene, substituted hydrocarbylene, heteroatom-containing hydrocarbylene, substituted heteroatom-containing hydrocarbylene, —O—, —S—, —NR 9 , and —PR 9 —, wherein R 9 is selected from hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, and substituted heteroatom-containing hydrocarbyl; and wherein the complex has a pyridine ligand, wherein the pyridine ligand and the ligand containing Q are bonded to M in a trans orientation. 8. The method for catalyzing an olefin metathesis reaction according to claim 1 , wherein the complex has the structure of formula (V) wherein: M is a Group 8 transition metal; R 1 and R 2 are independently selected from hydrogen, hydrocarbyl, substituted hydrocarbyl, heteroatom-containing hydrocarbyl, substituted heteroatom-containing hydrocarbyl, and functional groups; Q is an organic diradical; X 1 and X 2 are anionic ligands, and may be the same or different; L 1 is a neutral electron donor ligand, and p is zero or 1; and R 7 is selected from substituted and/or heteroatom-containing C

Assignees

Inventors

Classifications

  • Spiro-condensed systems · CPC title

  • Ruthenium compounds · CPC title

  • by isomerisation; by change of size of the carbon skeleton (introduction or elimination of carboxyl groups C07C67/313, C07C67/32) · CPC title

  • Homopolymers · CPC title

  • C08G61/02Primary

    Macromolecular compounds containing only carbon atoms in the main chain of the macromolecule, e.g. polyxylylenes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9238709B2 cover?
The invention provides novel organometallic complexes useful as olefin metathesis catalysts. The complexes have an N-heterocyclic carbene ligand and a chelating carbene ligand associated with a Group 8 transition metal center. The molecular structure of the complexes can be altered so as to provide a substantial latency period. The complexes are particularly useful in catalyzing ring closing me…
Who is the assignee on this patent?
Materia Inc, California Inst Of Techn
What technology area does this patent fall under?
Primary CPC classification C08G61/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).